![MRD response in relapsed/refractory FL after obinutuzumab plus bendamustine or bendamustine alone in the GADOLIN trial]()
MRD response in relapsed/refractory FL after obinutuzumab plus bendamustine or bendamustine alone in the GADOLIN trialPott, Christiane; Sehn, Laurie H.; Belada, David; Gribben, John; Hoster, Eva; Kahl, Brad; Kehden, Britta; Nicolas-Virelizier, Emmanuelle; Spielewoy, Nathalie; Fingerle-Rowson, Guenter; Harbron, Chris; Mundt, Kirsten; Wassner-Fritsch, Elisabeth; Cheson, Bruce D. · Leukemia · 2019